Skip to main content
. 2023 Jan 5;16:1–15. doi: 10.2147/IJNRD.S363041

Figure 2.

Figure 2

The alternative complement pathway with location of several sites of genetic defects (asterisk) and site of action of Eculizumab.

Abbreviations: aHUS, atypical hemolytic uremic syndrome; C3aR, C3a receptor; C5aR, C5a receptor; MAC, membrane attack complex.